Feasibility and efficacy of a weight gain prevention intervention for breast cancer patients receiving neoadjuvant chemotherapy: a randomized controlled pilot study
- 5 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Supportive Care in Cancer
- Vol. 28 (12), 5821-5832
- https://doi.org/10.1007/s00520-020-05411-2
Abstract
Purpose Weight gain is common among breast cancer patients and may contribute to poorer treatment outcomes. Most programs target breast cancer survivors after the completion of therapy and focus on weight reduction. This study examined the feasibility and preliminary efficacy of an intervention designed to prevent primary weight gain among women receiving neoadjuvant chemotherapy for breast cancer. Methods Thirty-eight newly diagnosed stage II or III breast cancer patients were randomized to the BALANCE intervention or usual care within 3 weeks of starting neoadjuvant chemotherapy. The intervention used a size acceptance-based approach and encouraged home-based resistance and moderate-intensity aerobic exercise as well as a low energy-dense diet to prevent weight gain. Assessments were conducted at baseline, mid-chemotherapy (3 months), and post-chemotherapy (6 months). Intervention feasibility, acceptability, and preliminary effects on anthropometric, quality of life, and circulating biomarker measures were evaluated. Results Intervention participant retention (100%) and in-person session attendance (80%) were high during the intervention period, although attendance dropped to 43% for telephone-delivered sessions. The majority of participants reported being satisfied with the intervention during chemotherapy (88%). Participants in the intervention group had greater reductions in waist circumference (p = .03) and greater improvements in self-reported vitality scores (p = .03) than the control group at the end of chemotherapy. Significant effects on biomarkers were not observed. Conclusions A size acceptance weight management program is feasible during neoadjuvant chemotherapy among breast cancer patients and may have beneficial effects on waist circumference and patient vitality. Trial registration This study was registered as a clinical trial at www.clinicaltrials.gov (NCT00533338).Funding Information
- National Cancer Institute (P30 CA016672)
This publication has 52 references indexed in Scilit:
- Weight Change and Its Correlates Among Breast Cancer SurvivorsNutrition and Cancer, 2011
- Comparison of SF-36 vitality scale and Fatigue Symptom Inventory in assessing cancer-related fatigueSupportive Care in Cancer, 2011
- Predictors and course of chronic fatigue in long-term breast cancer survivorsJournal of Cancer Survivorship, 2010
- Factors predicting clinically significant fatigue in women following treatment for primary breast cancerSupportive Care in Cancer, 2010
- Weight change patterns among breast cancer survivors: results from the Shanghai breast cancer survival studyCancer Causes & Control, 2009
- The frequency, magnitude and timing of post-diagnosis body weight gain in Dutch breast cancer survivorsEuropean Journal of Cancer, 2009
- Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancerCancer Causes & Control, 2008
- A Self-Regulation Program for Maintenance of Weight LossThe New England Journal of Medicine, 2006
- Obesity and Cardiovascular Risk Factors in Younger Breast Cancer Survivors: The Cancer and Menopause Study (CAMS)Breast Cancer Research and Treatment, 2005
- Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancerBreast Cancer Research and Treatment, 1985